Used in research to detect and inhibit the RAGE (Receptor for Advanced Glycation End-products) pathway, this antibody helps study chronic inflammatory conditions such as diabetes, Alzheimer's disease, and cardiovascular disorders. It is applied in immunoassays and tissue staining to quantify RAGE expression and evaluate its role in disease progression. Due to its specificity, it supports the development of targeted therapies aimed at reducing inflammation and cellular damage linked to sustained RAGE activation.